Advice Pool - Internet and Businesses Online

Not being able to convince Yahoo about creating a partnership to compete against Google

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

’s dominance in the online advertising field, Microsoft has announced the acquisition o

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

f giant digital advertising firm aQuantive for $6 billion.

Apparently, Microsoft has f

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

inally realized the growth potential of the online advertising business (expected to re

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ch $40 billion and growing at an annual 20% rate), and is now making some serious move

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

into the business. Microsoft’s last acquisition of aQuantive is actually the largest de

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

al in its history. Sounds like a huge deal, doesn’t it? But the question would be: isn’

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

t this too little, and most importantly, too late?

Let’s not forget that Microsoft lau

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ched AdCenter, its own advertising network, only one year ago; on the other hand, Googl

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

e, the market leader, with its superior search technology, has relied on a business mod

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

el based on online advertising since its creation over 8 years ago. In fact, Google’s s

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

pectacular revenue growth comes almost entirely from paid search advertising. Moreover,

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

as referenced on my previous post Search Engine Market Share, Google accounted for 65%

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

of all searches in April 2007, while Microsoft’s MSN was left with 9%. Clearly, this is

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

an area where the aQuantive acquisition will not help Microsoft. And if Microsoft’s pl

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

an is to concentrate on selling ads on publisher’s websites, rather than paid keywords

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

n search results, Google has that covered too with its recent acquisition of DoubleClic

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

k for $3.1 billion earlier this month.

Is there anything Microsoft and the rest of Goo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

gle’s competitors can still do to stop the bleeding? One thing is for sure true, Micros

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

oft won’t give up and this battle is getting very interesting. More to come, stay tuned

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/47854/advicepool-Online-Search-Battle-Continues.html">Online Search Battle Continues</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/47854/advicepool-Online-Search-Battle-Continues.html]Online Search Battle Continues[/url]

The main reason is to stop any potential lawsuits from happening! But do you know how many individuals I have talked to about this very thing? Many! Do you know what the majority have told me? They have locks and cameras, so they don’t need anymore security than that!

Thinking of starting in business for yourself? Before making the leap, considered the advantages and disadvantages of being the boss.

We all deserve to be appreciated, yet we tend to expect others to take notice automatically when we do something worthy of appreciation.

Tags

Links

Advice Pool - Online Search Battle Continues

Related Articles: